Tags

Type your tag names separated by a space and hit enter

Self-management for women with irritable bowel syndrome.
Clin Gastroenterol Hepatol 2004; 2(7):585-96CG

Abstract

BACKGROUND & AIMS

A randomized clinical trial was used to test the effectiveness of an 8-session multicomponent program (Comprehensive) compared to a Brief (single session) version and Usual Care for women with irritable bowel syndrome.

METHODS

Menstruating women, ages 18-48 years, were recruited from a health maintenance organization as well as community advertisements. Psychiatric nurse practitioners delivered both programs. The primary outcomes were improved symptoms, psychological distress, health-related quality of life, and indicators of stress-related hormones. Outcome indicators were measured at 3 points: (1) immediately after the Comprehensive program or 9 weeks after entry into the Usual Care and Brief Self-Management groups, (2) at 6 months, and (3) at 12 months.

RESULTS

Compared to Usual Care, women in the Comprehensive program had reduced gastrointestinal symptoms, psychological distress indicators, interruptions in activities because of symptoms, and enhanced quality of life that persisted at the 12-month follow-up evaluation. Women in the Brief group also demonstrated statistically significant improvements in quality of life and smaller nonsignificant improvements in other outcome variables than observed in the Comprehensive group. There were no group differences in urine catecholamines and cortisol levels.

CONCLUSIONS

A comprehensive self-management program is an important therapy approach for women with irritable bowel syndrome. The Brief 1-session version is also moderately helpful for some women with IBS.

Authors+Show Affiliations

Department of Behavioral Nursing and Health Systems, University of Washington, Seattle, 98195, USA. heit@u.washington.eduNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Clinical Trial
Comparative Study
Journal Article
Randomized Controlled Trial
Research Support, U.S. Gov't, P.H.S.

Language

eng

PubMed ID

15224283

Citation

Heitkemper, Margaret M., et al. "Self-management for Women With Irritable Bowel Syndrome." Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association, vol. 2, no. 7, 2004, pp. 585-96.
Heitkemper MM, Jarrett ME, Levy RL, et al. Self-management for women with irritable bowel syndrome. Clin Gastroenterol Hepatol. 2004;2(7):585-96.
Heitkemper, M. M., Jarrett, M. E., Levy, R. L., Cain, K. C., Burr, R. L., Feld, A., ... Weisman, P. (2004). Self-management for women with irritable bowel syndrome. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association, 2(7), pp. 585-96.
Heitkemper MM, et al. Self-management for Women With Irritable Bowel Syndrome. Clin Gastroenterol Hepatol. 2004;2(7):585-96. PubMed PMID: 15224283.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Self-management for women with irritable bowel syndrome. AU - Heitkemper,Margaret M, AU - Jarrett,Monica E, AU - Levy,Rona L, AU - Cain,Kevin C, AU - Burr,Robert L, AU - Feld,Andrew, AU - Barney,Pam, AU - Weisman,Pam, PY - 2004/6/30/pubmed PY - 2004/9/24/medline PY - 2004/6/30/entrez SP - 585 EP - 96 JF - Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association JO - Clin. Gastroenterol. Hepatol. VL - 2 IS - 7 N2 - BACKGROUND & AIMS: A randomized clinical trial was used to test the effectiveness of an 8-session multicomponent program (Comprehensive) compared to a Brief (single session) version and Usual Care for women with irritable bowel syndrome. METHODS: Menstruating women, ages 18-48 years, were recruited from a health maintenance organization as well as community advertisements. Psychiatric nurse practitioners delivered both programs. The primary outcomes were improved symptoms, psychological distress, health-related quality of life, and indicators of stress-related hormones. Outcome indicators were measured at 3 points: (1) immediately after the Comprehensive program or 9 weeks after entry into the Usual Care and Brief Self-Management groups, (2) at 6 months, and (3) at 12 months. RESULTS: Compared to Usual Care, women in the Comprehensive program had reduced gastrointestinal symptoms, psychological distress indicators, interruptions in activities because of symptoms, and enhanced quality of life that persisted at the 12-month follow-up evaluation. Women in the Brief group also demonstrated statistically significant improvements in quality of life and smaller nonsignificant improvements in other outcome variables than observed in the Comprehensive group. There were no group differences in urine catecholamines and cortisol levels. CONCLUSIONS: A comprehensive self-management program is an important therapy approach for women with irritable bowel syndrome. The Brief 1-session version is also moderately helpful for some women with IBS. SN - 1542-3565 UR - https://www.unboundmedicine.com/medline/citation/15224283/Self_management_for_women_with_irritable_bowel_syndrome_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S1542356504002423 DB - PRIME DP - Unbound Medicine ER -